Protein degradation as a target for anticancer therapy: molecular mechanisms of efficacy and acquired resistance to proteasome and aminopeptidase inhibitors

被引:0
|
作者
Peters, G. J. [1 ]
Ossenkoppele, G. J. [2 ]
Cloos, J. [2 ]
Jansen, G. [3 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Oncol Hematol, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:616 / 616
页数:1
相关论文
共 38 条
  • [1] Molecular Mechanisms of Acquired Proteasome Inhibitor Resistance
    Kale, Andrew J.
    Moore, Bradley S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (23) : 10317 - 10327
  • [2] MOLECULAR MECHANISMS OF ACQUIRED RESISTANCE TO KINASE INHIBITORS
    Sequist, L. V.
    ANNALS OF ONCOLOGY, 2012, 23 : 51 - 51
  • [3] MOLECULAR MECHANISMS OF ACQUIRED RESISTANCE TO EGFR TYROSINE KINASE INHIBITORS IN GBM
    Wykosky, Jill
    Cavenee, Webster
    Furnari, Frank
    NEURO-ONCOLOGY, 2011, 13 : 16 - 16
  • [4] Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
    J. Rafael Sierra
    Virna Cepero
    Silvia Giordano
    Molecular Cancer, 9
  • [5] Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
    Sierra, J. Rafael
    Cepero, Virna
    Giordano, Silvia
    MOLECULAR CANCER, 2010, 9
  • [6] Breast cancer resistance protein: Molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics
    Sugimoto, Y
    Tsukahara, S
    Ishikawa, E
    Mitsuhashi, J
    CANCER SCIENCE, 2005, 96 (08) : 457 - 465
  • [7] Exercise in cancer prevention and anticancer therapy: Efficacy, molecular mechanisms and clinical information
    Zhu, Chuanmei
    Ma, Hongbo
    He, Anqi
    Li, Yi
    He, Chengqi
    Xia, Yong
    CANCER LETTERS, 2022, 544
  • [8] Molecular mechanisms for synergistic effect of proteasome inhibitors with platinum-based therapy in solid tumors
    Chao, Angel
    Wang, Tzu-Hao
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2016, 55 (01): : 3 - 8
  • [9] Anaplastic lymphoma kinase inhibitors-a review of anticancer properties, clinical efficacy, and resistance mechanisms
    Kielbowski, Kajetan
    Zychowska, Justyna
    Becht, Rafal
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [10] MOLECULAR MECHANISMS OF SYNERGISTIC EFFECT OF PROTEASOME INHIBITORS AND PLATINUM-BASED THERAPY IN OVARIAN CANCER
    Wang, T.
    Chao, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1539 - 1539